Tolterodine Tartrate NDC 51407-739

NDC codes

FDA NDC Directory

Product NDC (as listed)51407-739Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51407-0739Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51407-739-05	51407073905	500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-739-05)Marketed from Aug 11, 2023
51407-739-30	51407073930	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-739-30)Marketed from Aug 11, 2023
51407-739-90	51407073990	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (51407-739-90)Marketed from Aug 11, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tolterodine Tartrate
Generic name (nonproprietary): tolterodine tartrate
Active ingredients: Tolterodine tartrate — 2 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Golden State Medical Supply, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204562
Marketing start: Aug 19, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 51407-739_47bbd926-55d2-107f-e063-6294a90a86f6SPL ID 47bbd926-55d2-107f-e063-6294a90a86f6SPL set ID 05b92da2-923b-3c04-e063-6394a90a69a1RxCUI 855182, 855189UNII 5T619TQR3R
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451407073905 followed by a unit qualifier and the quantity

Package 51407-0739-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 6, 2026.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Tolterodine tartrate extended-release capsules, USP are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency [see CLINICAL STUDIES (14) ] . Tolterodine tartrate extended-release capsules, USP are an antimuscarinic indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)